C
Cipherome
AI-driven data analysis platform enhancing healthcare research with predictive analytics, cohort querying, and automated summaries
About Cipherome
Cipherome operates in the healthcare and biotechnology sectors, focusing on leveraging artificial intelligence (AI) to enhance data analysis and research capabilities. The company serves healthcare providers, researchers, and pharmaceutical companies by offering a comprehensive data analysis platform known as COMPASS. This platform enables users to train AI models effortlessly, conduct statistical tests without coding, and define patient cohorts with precision. By automating tasks such as summarizing lengthy documents and generating social media posts, Cipherome aims to accelerate the research process and improve evidence-based decision-making. The business model is primarily subscription-based, generating revenue through platform access fees and premium features. Cipherome's market includes academic institutions, clinical research organizations, and biotech firms looking to optimize their data-driven research efforts.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2022 | $16M | $65M | Medivate Partners · InterVest · SIGNITE PARTNERS · Nautilus | ↗ |
Growth signals
Latest recorded traffic for Cipherome is 490 monthly website visits, down 55.5% over the last three months. Cipherome's team declined 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- MPMedivate Partners
InterVest
SIGNITE PARTNERS
Nautilus
Other known investors1 additional known investor
Nautilus Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cipherome on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cipherome’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







